Insulin-like growth factor 1 (IGF1) polymorphism is associated with Alzheimer's disease in Han Chinese

Neuroscience Letters

Volumn 531, Issue 1, 2012, Pages 20-23

  Wang, Wei ^a   Yu, Jin Tai ^a   Tan, Lan ^a   Liu, Qiu Yan ^a   Wang, Hui Fu ^a   Ma, Xiao Ying ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Genetic association; IGF1; Polymorphism

Indexed keywords

APOLIPOPROTEIN E; GENOMIC DNA; SOMATOMEDIN C;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; ETHNIC GROUP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAN CHINESE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84869083313     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.10.015     Document Type: Article

References (30)

1. Allen M., Cox C., Belbin O., Ma L., Bisceglio G.D., Wilcox S.L., Howell C.C., Hunter T.A., Culley O., Walker L.P., Carrasquillo M.M., Dickson D.W., Petersen R.C., Graff-Radford N.R., Younkin S.G., Ertekin-Taner N. Association and heterogeneity at the GAPDH locus in Alzheimer's disease. Neurobiology of Aging 2012, 33(1):203.e25-203.e33.
2. Alvarez A., Cacabelos R., Sanpedro C., García-Fantini M., Aleixandre M. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiology of Aging 2007, 28:533-536.
3. Al-Zahrani A., Sandhu M.S., Luben R.N., Thompson D., Baynes C., Pooley K.A., Luccarini C., Munday H., Perkins B., Smith P., Pharoah P.D., Wareham N.J., Easton D.F., Ponder B.A., Dunning A.M. IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1. IGFBP3 and risk of breast cancer. Human Molecular Genetics 2006, 15:1-10.
4. Bertram L., McQueen M.B., Mullin K., Blacker D., Tanzi R.E. Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database. Nature Genetics 2007, 39:17-23.
5. Bertram L., Tanzi R.E. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nature Reviews Neuroscience 2008, 9:768-778.
6. Brzozowski A.M., Dodson E.J., Dodson G.G., Murshudov G.N., Verma C., Turkenburg J.P., de Bree F.M., Dauter Z. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. Biochemistry 2002, 41(30):9389-9397.
7. Carro E., Spuch C., Trejo J.L., Antequera D., Torres-Aleman I. Choroid plexus megalin is involved in neuroprotection by serum insulin-like growth factor. I. Journal of Neuroscience 2005, 25:10884-10893.
8. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W., Roses A.D., Haines J.L., Pericak-Vance M.A. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993, 261(5123):921-923.
9. Corvin A.P., Molinos I., Little G., Donohoe G., Gill M., Morris D.W., Tropea D. Insulin-like growth factor 1 (IGF1) and its active peptide (1-3) IGF1 enhance the expression of synaptic markers in neuronal circuits through different cellular mechanisms. Neuroscience Letters 2012, 520(1):51-56.
10. de la Monte S.M., Wands J.R. Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: relevance to Alzheimer's disease. Journal of Alzheimer's Disease 2005, 7(1):45-61.
11. Farrer L.A., Cupples L.A., Haines J.L., Hyman B., Kukull W.A., Mayeux R., Myers R.H., Pericak-Vance M.A., Risch N., van Duijn C.M. Effects of age. sex. and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. ApoE and Alzheimer Disease Meta Analysis Consortium. Journal of the American Medical Association 1997, 278(16):1349-1356.
12. Folli F., Ghidella S., Bonfanti L., Kahn C.R., Merighi A. The early intracellular signaling pathway for the insulin/insulin-like growth factor receptor family in the mammalian central nervous system. Molecular Neurobiology 1996, 13(2):155-183.
13. Freude S., Schilbach K., Schubert M. The role of IGF-1 receptor and insulin receptor signaling for the pathogenesis of Alzheimer's disease: from model organisms to human disease. Current Alzheimer Research 2009, 6(3):213-223.
14. Gasparini L., Xu H. Potential roles of insulin and IGF-1 in Alzheimer's disease. Trends in Neurosciences 2003, 26(8):404-406.
15. Gatz M., Reynolds C.A., Fratiglioni L., Johansson B., Mortimer J.A., Berg S., Fiske A., Pedersen N.L. Role of genes and environments for explaining Alzheimer disease. Archives of General Psychiatry 2006, 63:168-174.
16. Gregoire J.M., Romeo P.H. T-cell expression of the human GATA-3 gene is regulated by a non-lineage-specific silencer. Journal of Biological Chemistry 1999, 274(10):6567-6578.
17. Jun G., Naj A.C., Beecham G.W., Wang L.S., Buros J., Gallins P.J., Buxbaum J.D., Ertekin-Taner N., Fallin M.D., Friedland R., Inzelberg R., Kramer P., Rogaeva E., St George-Hyslop P., Alzheimer's Disease Genetics Consortium, Cantwell L.B., Dombroski B.A., Saykin A.J., Reiman E.M., Bennett D.A., Morris J.C., Lunetta K.L., Martin E.R., Montine T.J., Goate A.M., Blacker D., Tsuang D.W., Beekly D., Cupples L.A., Hakonarson H., Kukull W., Foroud T.M., Haines J., Mayeux R., Farrer L.A., Pericak-Vance M.A., Schellenberg G.D. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with ApoE genotypes. Archives of Neurology 2010, 67(12):1473-1484.
18. Lin P.I., Vance J.M., Pericak-Vance M.A., Martin E.R. No gene is an island: the flip-flop phenomenon. American Journal of Human Genetics 2007, 80(3):531-538.
19. McKhann G., Drachman D., Folstein M. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
20. Nacmias B., Tedde A., Bagnoli S., Cellini E., Guarnieri B.M., Piacentini S., Sorbi S. Implication of GAB2 gene polymorphism in Italian patients with Alzheimer's disease. Journal of Alzheimer's Disease 2009, 16(3):513-515.
21. Pratico D., Trojanowski J.Q. Inflammatory hypothesis: novel mechanisms of Alzheimer's neurodegeneration and new therapeutic targets?. Neurobiology of Aging 2000, 21:441-445.
22. Querfurth H.W., LaFerla F.M. Alzheimer's disease. New England Journal of Medicine 2010, 362:329-344.
23. Rollero A., Murialdo G., Fonzi S., Garrone S., Gianelli M.V., Gazzerro E., Barreca A., Polleri A. Relationship between cognitive function. growth hormone and insulin-like growth factor I plasma levels in aged subjects. Neuropsychobiology 1998, 38:73-79.
24. Russo V.C., Gluckman P.D., Feldman E.L., Werther G.A. The insulin-like growth factor system and its pleiotropic functions in brain. Endocrine Reviews 2005, 26(7):916-943.
25. Siddle K., Ursø B., Niesler C.A., Cope D.L., Molina L., Surinya K.H., Soos M.A. Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochemical Society Transactions 2001, 29(Pt 4):513-525.
26. Torres-Aleman I. Toward a comprehensive neurobiology of IGF-1. Developmental Neurobiology 2010, 70(5):384-396.
27. Vargas T., Bullido M.J., Martinez-Garcia A., Antequera D., Clarimon J., Rosich-Estrago M., Martin-Requero A., Mateo I., Rodriguez-Rodriguez E., Vilella-Cuadrada E., Frank A., Lleo A., Molina-Porcel L., Blesa R., Combarros O., Gomez-Isla T., Bermejo-Pareja F., Valdivieso F., Carro E. A megalin polymorphism associated with promoter activity and Alzheimer's disease risk. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2010, 153B:895-902.
28. Vargas T., Martinez-Garcia A., Antequera D., Vilella E., Clarimon J., Mateo I., Sanchez-Juan P., Rodriguez-Rodriguez E., Frank A., Rosich-Estrago M., Lleo A., Molina-Porcel L., Blesa R., Gomez-Isla T., Combarros O., Bermejo-Pareja F., Valdivieso F., Bullido M.J., Carro E. IGF-I gene variability is associated with an increased risk for AD. Neurobiology of Aging 2011, 32(3):556.e3-556.e11.
29. Watanabe T., Miyazaki A., Katagiri T., Yamamoto H., Idei T., Iguchi T. Relationship between serum insulin-like growth factor-1 levels and Alzheimer's disease and vascular dementia. Journal of the American Geriatrics Society 2005, 53(10):1748-1753.
30. Záková L., Brynda J., Au-Alvarez O., Dodson E.J., Dodson G.G., Whittingham J.L., Brzozowski A.M. Toward the insulin-IGF-I intermediate structures: functional and structural properties of the [TyrB25NMePheB26] insulin mutant. Biochemistry 2004, 43(51):16293-16300.